다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

TXG

10x Genomics (TXG)

10x Genomics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TXG

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/03	05:05	PR Newswire (US)	10x Genomics to Present at the BofA Securities 2024 Healthcare Conference	NASDAQ:TXG	10x Genomics Inc
2024/05/01	05:05	PR Newswire (US)	10x Genomics Reports First Quarter 2024 Financial Results	NASDAQ:TXG	10x Genomics Inc
2024/04/11	05:05	PR Newswire (US)	10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024	NASDAQ:TXG	10x Genomics Inc
2024/03/26	22:00	PR Newswire (US)	10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay	NASDAQ:TXG	10x Genomics Inc
2024/03/22	05:05	PR Newswire (US)	10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	NASDAQ:TXG	10x Genomics Inc
2024/03/14	05:05	PR Newswire (US)	10x Genomics Begins Commercial Shipments of Chromium GEM-X Products	NASDAQ:TXG	10x Genomics Inc
2024/03/07	06:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/03/05	08:40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/27	06:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/27	06:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/27	06:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/23	09:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/23	09:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/23	08:59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/21	06:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/21	06:05	PR Newswire (US)	10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference	NASDAQ:TXG	10x Genomics Inc
2024/02/16	07:33	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TXG	10x Genomics Inc
2024/02/16	07:16	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:TXG	10x Genomics Inc
2024/02/16	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXG	10x Genomics Inc
2024/02/16	06:05	PR Newswire (US)	10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024	NASDAQ:TXG	10x Genomics Inc
2024/02/14	06:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/02/08	06:05	PR Newswire (US)	10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology	NASDAQ:TXG	10x Genomics Inc
2024/02/06	06:05	PR Newswire (US)	10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General Meeting	NASDAQ:TXG	10x Genomics Inc
2024/01/25	06:05	PR Newswire (US)	10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024	NASDAQ:TXG	10x Genomics Inc
2024/01/19	06:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc
2024/01/17	08:08	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TXG	10x Genomics Inc
2024/01/17	06:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXG	10x Genomics Inc
2024/01/08	23:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TXG	10x Genomics Inc
2024/01/08	23:00	PR Newswire (US)	10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results	NASDAQ:TXG	10x Genomics Inc
2023/12/30	06:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TXG	10x Genomics Inc

검색 관련기사 보기:NASDAQ:TXG

1 2 3 4 5 6 7 8 9 10 다음 >>

Skye Bioscience (QB)

Allegiant Travel

Companhia Parana De Energ

KFA Large Cap Quality Di...

Horizons Active AI Globa...

Lehman ABS (PK)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관